Skip to content

Opioid free general anesthesia combined with lidocaine and dexmedetomidine infusion for radical mastectomy of breast cancer

Opioid free general anesthesia combined with lidocaine and dexmedetomidine infusion for radical mastectomy of breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073912
Enrollment
Unknown
Registered
2023-07-25
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Opioid-free group:Intravenous lidocaine 2mg/kg at induction, intravenous dexmedetomidine 1µg/kg, preoperative diamond intercostal block with ropivacaine, intraoperative continuous pumping of dexmedeto
Control group:Conventional general anesthesia with opioids

Sponsors

Weifang City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 20-70 years, ASA grade I-II, undergoing modified radical mastectomy for breast cancer

Exclusion criteria

Exclusion criteria: Patients with BMI > 26, history of local anesthetic allergy, severe respiratory, renal or hepatic disease, preoperative opioid use and history of psychiatric disorders. Patients with severe hypotension (mean arterial pressure [MAP] < 60mmhg) or bradycardia (heart rate [HR] < 40bpm), cardiac arrhythmias or urticaria caused by intraoperative infusion of lidocaine and dexmedetomidine

Design outcomes

Primary

MeasureTime frame
Pain score;Time of first postoperative venting;

Secondary

MeasureTime frame
Incidence of postoperative nausea and vomiting;Extubation time;Intraoperative hemodynamics;

Countries

China

Contacts

Public ContactBao Lang

Weifang City People's Hospital

wfrmyy91@163.com+86 135 1540 0832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026